Eidos Therapeutics confirms receipt of non-binding proposal from BridgeBio Pharma to acquire shares

Image: Eidos Therapeutics has confirmed receipt of non-binding proposal from BridgeBio Pharma to acquire shares. Photo: courtesy of Robert-Owen-Wahl from Pixabay.